Cargando…

Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine

Detalles Bibliográficos
Autores principales: Ruhe, Johannes, Schnetzke, Ulf, Kentouche, Karim, Prims, Florian, Baier, Michael, Herfurth, Konstantin, Schlosser, Mandy, Busch, Martin, Hochhaus, Andreas, Wolf, Gunter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311064/
https://www.ncbi.nlm.nih.gov/pubmed/34309715
http://dx.doi.org/10.1007/s00277-021-04584-y
_version_ 1783728887032709120
author Ruhe, Johannes
Schnetzke, Ulf
Kentouche, Karim
Prims, Florian
Baier, Michael
Herfurth, Konstantin
Schlosser, Mandy
Busch, Martin
Hochhaus, Andreas
Wolf, Gunter
author_facet Ruhe, Johannes
Schnetzke, Ulf
Kentouche, Karim
Prims, Florian
Baier, Michael
Herfurth, Konstantin
Schlosser, Mandy
Busch, Martin
Hochhaus, Andreas
Wolf, Gunter
author_sort Ruhe, Johannes
collection PubMed
description
format Online
Article
Text
id pubmed-8311064
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83110642021-07-26 Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine Ruhe, Johannes Schnetzke, Ulf Kentouche, Karim Prims, Florian Baier, Michael Herfurth, Konstantin Schlosser, Mandy Busch, Martin Hochhaus, Andreas Wolf, Gunter Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2021-07-26 2022 /pmc/articles/PMC8311064/ /pubmed/34309715 http://dx.doi.org/10.1007/s00277-021-04584-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Ruhe, Johannes
Schnetzke, Ulf
Kentouche, Karim
Prims, Florian
Baier, Michael
Herfurth, Konstantin
Schlosser, Mandy
Busch, Martin
Hochhaus, Andreas
Wolf, Gunter
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
title Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
title_full Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
title_fullStr Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
title_full_unstemmed Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
title_short Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
title_sort acquired thrombotic thrombocytopenic purpura after first vaccination dose of bnt162b2 mrna covid-19 vaccine
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311064/
https://www.ncbi.nlm.nih.gov/pubmed/34309715
http://dx.doi.org/10.1007/s00277-021-04584-y
work_keys_str_mv AT ruhejohannes acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT schnetzkeulf acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT kentouchekarim acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT primsflorian acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT baiermichael acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT herfurthkonstantin acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT schlossermandy acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT buschmartin acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT hochhausandreas acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine
AT wolfgunter acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine